Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
4,81 USD | +0,84% | -22,42% | -60,17% |
Métier
Nombre d'employés: 3
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 57 | 01/08/22 | |
David Jin
DFI | Director of Finance/CFO | 34 | - |
Michael Ryan
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/18 |
Scott A. Reines
CTO | Chief Tech/Sci/R&D Officer | 77 | 01/01/16 |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 68 | 09/02/15 | |
Jay Kranzler
CHM | Chairman | 66 | 01/02/17 |
Neil Herskowitz
BRD | Director/Board Member | 67 | 01/08/15 |
Faith Charles
BRD | Director/Board Member | 62 | 16/05/22 |
Curtis Oltmans
BRD | Director/Board Member | 60 | 01/04/21 |
Chief Executive Officer | 57 | 01/08/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 590 143 | 520 427 ( 88,19 %) | 0 | 88,19 % |
Action B | 0 | 250 000 | 0 | 0 |
Coordonnées société
Avenue Therapeutics, Inc.
1111 Kane Concourse Suite 301
33154, Bay Harbor Islands
+781 652 4500
http://www.avenuetx.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-60,17% | 2,81 M | |
-1,47% | 103 Md | |
+9,04% | 101 Md | |
+4,40% | 23,07 Md | |
-12,18% | 22,23 Md | |
-4,36% | 18,05 Md | |
-39,98% | 17,18 Md | |
-10,23% | 16,94 Md | |
+6,84% | 14,07 Md | |
+38,66% | 12,35 Md |
- Bourse
- Actions
- Action ATXI
- Société Avenue Therapeutics, Inc.